Product Code: ETC10414169 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Regenerative Medicines Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Regenerative Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Regenerative Medicines Market - Industry Life Cycle |
3.4 Mexico Regenerative Medicines Market - Porter's Five Forces |
3.5 Mexico Regenerative Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Regenerative Medicines Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 Mexico Regenerative Medicines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Mexico Regenerative Medicines Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Mexico Regenerative Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Mexico, leading to a higher demand for regenerative medicines. |
4.2.2 Growth in healthcare infrastructure and investment in research and development within the regenerative medicine sector. |
4.2.3 Favorable government regulations and policies supporting the adoption and development of regenerative medicines. |
4.3 Market Restraints |
4.3.1 High costs associated with regenerative medicines, limiting access to a wider population. |
4.3.2 Limited awareness and understanding of regenerative medicine therapies among healthcare professionals and patients in Mexico. |
5 Mexico Regenerative Medicines Market Trends |
6 Mexico Regenerative Medicines Market, By Types |
6.1 Mexico Regenerative Medicines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Regenerative Medicines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Mexico Regenerative Medicines Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.1.4 Mexico Regenerative Medicines Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.5 Mexico Regenerative Medicines Market Revenues & Volume, By Tissue Engineering, 2021 - 2031F |
6.1.6 Mexico Regenerative Medicines Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.7 Mexico Regenerative Medicines Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.2 Mexico Regenerative Medicines Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Regenerative Medicines Market Revenues & Volume, By Mesenchymal Stem Cells, 2021 - 2031F |
6.2.3 Mexico Regenerative Medicines Market Revenues & Volume, By Viral Vector Delivery, 2021 - 2031F |
6.2.4 Mexico Regenerative Medicines Market Revenues & Volume, By Biomaterials-Based, 2021 - 2031F |
6.2.5 Mexico Regenerative Medicines Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F |
6.2.6 Mexico Regenerative Medicines Market Revenues & Volume, By Drug-Based Regeneration, 2021 - 2031F |
6.3 Mexico Regenerative Medicines Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Mexico Regenerative Medicines Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3.3 Mexico Regenerative Medicines Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.3.4 Mexico Regenerative Medicines Market Revenues & Volume, By Organ Transplant, 2021 - 2031F |
6.3.5 Mexico Regenerative Medicines Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.3.6 Mexico Regenerative Medicines Market Revenues & Volume, By Wound Healing, 2021 - 2031F |
6.4 Mexico Regenerative Medicines Market, By End-Use |
6.4.1 Overview and Analysis |
6.4.2 Mexico Regenerative Medicines Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.4.3 Mexico Regenerative Medicines Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.4.4 Mexico Regenerative Medicines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.5 Mexico Regenerative Medicines Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.4.6 Mexico Regenerative Medicines Market Revenues & Volume, By Dermatology Clinics, 2021 - 2031F |
7 Mexico Regenerative Medicines Market Import-Export Trade Statistics |
7.1 Mexico Regenerative Medicines Market Export to Major Countries |
7.2 Mexico Regenerative Medicines Market Imports from Major Countries |
8 Mexico Regenerative Medicines Market Key Performance Indicators |
8.1 Number of clinical trials and research studies being conducted in the field of regenerative medicines in Mexico. |
8.2 Adoption rate of regenerative medicine therapies in different healthcare facilities across Mexico. |
8.3 Investment trends in regenerative medicine startups and companies in the Mexican market. |
9 Mexico Regenerative Medicines Market - Opportunity Assessment |
9.1 Mexico Regenerative Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Regenerative Medicines Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 Mexico Regenerative Medicines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Mexico Regenerative Medicines Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Mexico Regenerative Medicines Market - Competitive Landscape |
10.1 Mexico Regenerative Medicines Market Revenue Share, By Companies, 2024 |
10.2 Mexico Regenerative Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |